Latest Insider Transactions at Organogenesis Holdings Inc. (ORGO)
This section provides a real-time view of insider transactions for Organogenesis Holdings Inc. (ORGO). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Organogenesis Holdings Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Organogenesis Holdings Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 15
2021
|
Dennis Erani 2012 Issue Trust Dated 12/20/12 > 10% Shareholder |
SELL
Bona fide gift
|
Indirect |
5,417,900
-8.35%
|
-
|
|
Dec 15
2021
|
Dennis Erani > 10% Shareholder |
BUY
Bona fide gift
|
Direct |
5,417,900
+8.35%
|
-
|
|
Dec 15
2021
|
Dennis Erani > 10% Shareholder |
SELL
Bona fide gift
|
Indirect |
5,417,900
-8.35%
|
-
|
|
Dec 13
2021
|
Michael W Katz > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
500
+0.82%
|
$4,500
$9.65 P/Share
|
|
Dec 03
2021
|
Michael W Katz > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
800
+1.32%
|
$7,200
$9.35 P/Share
|
|
Dec 02
2021
|
Michael W Katz > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
1,800
+1.51%
|
$16,200
$9.65 P/Share
|
|
Nov 29
2021
|
Michael W Katz > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
1,000
+1.72%
|
$9,000
$9.75 P/Share
|
|
Nov 26
2021
|
Michael W Katz > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
2,000
+1.76%
|
$18,000
$9.79 P/Share
|
|
Nov 19
2021
|
Prathyusha Duraibabu Director |
BUY
Grant, award, or other acquisition
|
Direct |
11,340
+50.0%
|
-
|
|
Nov 18
2021
|
Glenn H Nussdorf Director |
BUY
Open market or private purchase
|
Direct |
25,000
+0.04%
|
$225,000
$9.93 P/Share
|
|
Nov 18
2021
|
Gn 2016 Organo 10 Year Grat U/A/D September 30, 2016 > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
25,000
+0.04%
|
$225,000
$9.93 P/Share
|
|
Nov 17
2021
|
Michael W Katz > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
1,000
+1.81%
|
$10,000
$10.87 P/Share
|
|
Nov 15
2021
|
Michael W Katz > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
1,000
+1.84%
|
$11,000
$11.08 P/Share
|
|
Nov 12
2021
|
Michael W Katz > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
3,000
+2.82%
|
$33,000
$11.15 P/Share
|
|
Nov 10
2021
|
Patrick Bilbo Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
30,450
+18.55%
|
$30,450
$1.44 P/Share
|
|
Aug 17
2021
|
Michael W Katz > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
12,000
+19.58%
|
$156,000
$13.55 P/Share
|
|
Aug 03
2021
|
Arthur S Leibowitz Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+9.56%
|
-
|
|
Jul 19
2021
|
Gary S. Gillheeney President and CEO |
SELL
Open market or private sale
|
Direct |
160,237
-54.85%
|
$2,243,318
$14.02 P/Share
|
|
Jul 19
2021
|
Gary S. Gillheeney President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
160,237
+35.42%
|
$0
$0.99 P/Share
|
|
Jul 16
2021
|
Gary S. Gillheeney President and CEO |
SELL
Open market or private sale
|
Direct |
139,763
-29.43%
|
$1,956,682
$14.96 P/Share
|
|
Jul 16
2021
|
Gary S. Gillheeney President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
139,763
+21.64%
|
$279,526
$2.52 P/Share
|
|
Jun 09
2021
|
Albert Erani Family Trust Dated 12/29/2012 > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
150,000
-0.25%
|
$2,250,000
$15.31 P/Share
|
|
Jun 09
2021
|
Albert Erani > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
150,000
-0.25%
|
$2,250,000
$15.31 P/Share
|
|
Jun 08
2021
|
Albert Erani Family Trust Dated 12/29/2012 > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
100,000
-0.17%
|
$1,500,000
$15.41 P/Share
|
|
Jun 08
2021
|
Albert Erani > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
100,000
-0.17%
|
$1,500,000
$15.41 P/Share
|
|
Jun 07
2021
|
Albert Erani Family Trust Dated 12/29/2012 > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
94,612
-0.16%
|
$1,513,792
$16.14 P/Share
|
|
Jun 07
2021
|
Albert Erani > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
94,612
-0.16%
|
$1,513,792
$16.14 P/Share
|
|
Jun 04
2021
|
Albert Erani Family Trust Dated 12/29/2012 > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
60,000
-0.1%
|
$960,000
$16.22 P/Share
|
|
Jun 04
2021
|
Albert Erani > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
60,000
-0.1%
|
$960,000
$16.22 P/Share
|
|
May 27
2021
|
Dennis Erani > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
9,106
-0.69%
|
$163,908
$18.97 P/Share
|
|
May 27
2021
|
Alan A. Ades Director |
SELL
Open market or private sale
|
Direct |
3,887,500
-6.1%
|
$62,200,000
$16.4 P/Share
|
|
May 27
2021
|
Glenn H Nussdorf Director |
SELL
Open market or private sale
|
Direct |
3,887,500
-6.1%
|
$62,200,000
$16.4 P/Share
|
|
May 14
2021
|
Avista Capital Managing Member Iv, LLC |
SELL
Other acquisition or disposition
|
Indirect |
21,154,526
-73.26%
|
-
|
|
May 07
2021
|
Jon L Giacomin Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,319
+50.0%
|
-
|
|
May 06
2021
|
Alan A. Ades Director |
BUY
Other acquisition or disposition
|
Direct |
19,550,714
+6.09%
|
-
|
|
May 06
2021
|
Alan A. Ades Director |
SELL
Other acquisition or disposition
|
Direct |
23,855,148
-35.07%
|
-
|
|
May 06
2021
|
Glenn H Nussdorf Director |
BUY
Other acquisition or disposition
|
Direct |
19,550,714
+6.09%
|
-
|
|
May 06
2021
|
Glenn H Nussdorf Director |
SELL
Other acquisition or disposition
|
Direct |
23,855,148
-35.07%
|
-
|
|
Apr 09
2021
|
Starr Wisdom > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
20,000
-50.0%
|
$440,000
$22.11 P/Share
|
|
Apr 01
2021
|
Antonio S. Montecalvo Vice President, Health Policy |
SELL
Payment of exercise price or tax liability
|
Direct |
1,770
-2.48%
|
$33,630
$19.83 P/Share
|
|
Apr 01
2021
|
Gary S. Gillheeney President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,265
-4.48%
|
$119,035
$19.83 P/Share
|
|
Apr 01
2021
|
Lori Freedman Chief Admin. and Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,975
-5.53%
|
$37,525
$19.83 P/Share
|
|
Apr 01
2021
|
Patrick Bilbo Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,497
-1.5%
|
$47,443
$19.83 P/Share
|
|
Apr 01
2021
|
Brian Grow Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,977
-4.25%
|
$37,563
$19.83 P/Share
|
|
Mar 01
2021
|
Starr Wisdom > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
8,050
-16.75%
|
$128,800
$16.5 P/Share
|
|
Feb 25
2021
|
Starr Wisdom > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
29,335
-19.64%
|
$440,025
$15.61 P/Share
|
|
Feb 24
2021
|
Starr Wisdom > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
15,154
-16.38%
|
$212,156
$14.7 P/Share
|
|
Feb 18
2021
|
Gary S. Gillheeney President and CEO |
SELL
Open market or private sale
|
Direct |
16,663
-10.65%
|
$199,956
$12.85 P/Share
|
|
Feb 17
2021
|
Gary S. Gillheeney President and CEO |
SELL
Open market or private sale
|
Direct |
89,375
-19.24%
|
$1,161,875
$13.56 P/Share
|
|
Feb 16
2021
|
Starr Wisdom > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
170,000
-64.75%
|
$2,040,000
$12.95 P/Share
|